Patents

Patent issued for exosome technology - a new approach to immunology

Published in Cancer Weekly, March 9th, 2004

Anosys, Inc., announced that the United States Patent and Trademark Office has issued Patent No. 6,685,911, the first patent in the U.S. related to exosomes, a new, fundamental approach to immunology.

This technology is applicable to the development of therapeutics and diagnostics for a broad range of diseases.

Anosys' most advanced, exosome-based program has focused on the development of new cancer therapies. The company has completed a phase I clinical study in the U.S. in patients with advanced non-small cell lung cancer (NSCLC) who have failed current therapies, and a second phase I trial in Europe in advanced melanoma patients. Anosys...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-03-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry